You are here: Industry Insights > Avalon GloboCare

News List

Avalon GloboCare Announces Execution of Purchase Agreement for Acquisition of SenlangBio in All Stock Transaction firstwordpharma
June 15, 2021
Avalon GloboCare Corp. (NASDAQ: AVCO) , a clinical-stage global developer of cell-based technologies and therapeutics, today announced that it has entered into a definitive agreement to acquire Hebei Senlang Biotechnology Co. Ltd.
Avalon GloboCare to develop intranasal and oral Covid-19 vaccine pharmaceutical-technology
June 28, 2020
US-based biotech firm Avalon GloboCare has collaborated with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine against Covid-19 for intranasal or oral administration.
Avalon GloboCare Partners with China (Nanjing) Cell Valley to Advance Cellular Medicines firstwordpharma
December 22, 2019
Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today announced it has established a strategic partnership with China (Nanjing) Cell Valley ("CNCV"). CNCV is currently one of the large
Avalon GloboCare, GE Healthcare to accelerate bioproduction of cellular medicines biospectrumasia
July 23, 2019
The partnership combines GE Healthcare’s renowned expertise in the design and development of innovative bio-manufacturing technologies and Avalon’s scientific and clinical expertise for the cellular medicine industry